ClinicalTrials.Veeva

Menu

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model Study

W

Wuhan University

Status

Unknown

Conditions

Cardiovascular Diseases
NAFLD

Study type

Observational

Funder types

Other

Identifiers

NCT03534908
WDRY2017-K009

Details and patient eligibility

About

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world. NAFLD is associated with a lot of comorbidity, such as diabetes, metabolic syndrome, coronary heart disease and chronic kidney diseases. However, the correlation between the NAFLD and cardiovascular disease (CVD) events remains controversial. This study is an observational study based on a big retrospective cohort in china to explore the prevalence of NAFLD in China, the risk factors associated with NAFLD, as well as whether patients with NAFLD are more prone to experience CVDs and CVD events.

Enrollment

5,000,000 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • males or females aged 18-75

Exclusion criteria

  • malignancy except primary liver cancer
  • pregnancy or breastfeeding
  • liver diseases of other etiology including hepatitis C virus infection ,autoimmune hepatitis,Wilson's disease,hemachromatosis,drug-induced hepatitis,parenteral nutrition
  • excessive alcohol consumption
  • cases missing crucial data

Trial design

5,000,000 participants in 2 patient groups

NAFLD group
Description:
those with NAFLD
Control group
Description:
those without NAFLD

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems